Portia NDC 0555-9020

NDC codes

FDA NDC Directory

Product NDC (as listed)0555-9020Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00555-9020Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0555-9020-58	00555902058	6 POUCH in 1 CARTON (0555-9020-58) / 1 BLISTER PACK in 1 POUCH (0555-9020-79) / 1 KIT in 1 BLISTER PACKMarketed from Jun 27, 2002

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Portia
Generic name (nonproprietary): levonorgestrel and ethinyl estradiol
Dosage form: Kit
Labeler: Teva Pharmaceuticals USA, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075866
Marketing start: Jun 27, 2002
Listing expires: Dec 31, 2026
Identifiers: Product ID 0555-9020_4d63fa4a-ff46-4f2e-b9d5-cab4f5fe1d85SPL ID 4d63fa4a-ff46-4f2e-b9d5-cab4f5fe1d85SPL set ID c78b236b-85c4-4258-a524-cea08775100cRxCUI 238019, 748797, 748878, 751890

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400555902058 followed by a unit qualifier and the quantity

Package 00555-9020-58. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 12, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Portia ® (levonorgestrel and ethinyl estradiol tablets USP) is indicated for use by females of reproductive potential to prevent pregnancy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)